| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 144 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 144 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 144 |
| 3 | CYTARABINE | 134 |
| 4 | METHOTREXATE SODIUM | 119 |
| 5 | DEXAMETHASONE | 116 |
| 6 | METHOTREXATE | 116 |
| 7 | DEXAMETHASONE 1.5 MG | 115 |
| 8 | PREDNISONE | 102 |
| 9 | FLUDARABINE PHOSPHATE | 82 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEMTUZUMAB OZOGAMICIN | 20 | 0.0055 |
| 1 | CLOFARABINE | 11 | 0.0048 |
| 2 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 10 | 0.0041 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 34 | 0.0041 |
| 4 | TREOSULFAN | 11 | 0.0040 |
| 5 | CLEMASTINE FUMARATE | 5 | 0.0036 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 21 | 0.0033 |
| 7 | THIOTEPA | 30 | 0.0031 |
| 8 | AMIKACIN SULFATE | 5 | 0.0029 |
| 9 | ISOFLURANE | 5 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 284 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 187 |
| 2 | Alkylating Drug [EPC] | 168 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 123 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 113 |
| 5 | Benzodiazepine [EPC] | 77 |
| 6 | Topoisomerase Inhibitor [EPC] | 71 |
| 7 | Platinum-based Drug [EPC] | 68 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 63 |
| 9 | Leukocyte Growth Factor [EPC] | 62 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 20 | 0.0055 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 10 | 0.0041 |
| 2 | CD22-directed Immunoconjugate [EPC] | 6 | 0.0020 |
| 3 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 4 | Asparagine-specific Enzyme [EPC] | 20 | 0.0015 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 6 | Antimalarial [EPC] | 12 | 0.0011 |
| 7 | Antiseptic [EPC] | 5 | 0.0011 |
| 8 | Antiprotozoal [EPC] | 12 | 0.0011 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |